Preclinical Contract Research Organisation for Immunology

Propel your drug discovery breakthroughs with RoukenBio, Discovery CRO redefined.

We solve problems. We deliver quality data. We take your project to the next milestone. We are RoukenBio, the immunology CRO covering the full spectrum of discovery to pre-IND testing.

Net Promoter Score - our clients love working with us

Countries with customers globally

100+

Employees and growing

484

square meters of lab space with state-of-the-art instruments

MORE ABOUT US

Solutions

As a discovery contract research organisation, RoukenBio provides drug development services to support a global customer base to develop small molecule, large molecule and advanced therapeutics from early discovery through to clinical phases.

Phase

RoukenBio supports innovative biotechnology companies from the earliest phases of drug discovery through to clinical development. Our decades of academic expertise are combined with hands-on, practical industry experience of driving large molecule and advanced therapies forward.

See how assay development unfolds through phases

Modalities

Our multidisciplinary team of scientific experts are seasoned at supporting the development of a wide range of therapeutic modalities, possessing knowledge of the unique challenges associated across these classes. Our collective accomplishments across different therapeutic areas, combined with our state-of-the-art assay platforms and custom development capabilities, makes us the perfect partner for your drug development journey.

Explore all modalities

Therapeutic focus

At RoukenBio, our experience spans across a diverse range of therapeutic fields, making us the premier partner for the development of innovative therapies. We translate this into actionable strategies that ensure we comprehend the critical elements of disease biology that are relevant to your therapeutic goals, allowing us to grasp the nuances of what you are trying to achieve at each stage.

Explore our therapeutic expertise

Preclinical Contract Research Organisation for Immunology

Propel your drug discovery breakthroughs with RoukenBio, Discovery CRO redefined.

Explore our services Speak to an expert

We solve problems. We deliver quality data. We take your project to the next milestone. We are RoukenBio, the immunology CRO covering the full spectrum of discovery to pre-IND testing.

Net Promoter Score - our clients love working with us

Countries with customers globally

100+

Employees and growing

484

square meters of lab space with state-of-the-art instruments

MORE ABOUT US

Solutions

What our customers say

Explore genuine feedback and testimonials from our clients.

"It has been a pleasure working closely with RoukenBio to evaluate the functional activity of our IgM antibodies in ex vivo primary cell assays. The scientific team at RoukenBio feels like an extension of our internal Preclinical Sciences team since they readily provide trouble-shooting input. Through multiple successful collaborations, RoukenBio has consistently delivered high quality, robust data. I highly recommend working with them!"

Maya Kotturi, Ph.D

Executive Director - Translational Research

"We initially reached out to RoukenBio 3 years ago to run intricate cell-based assays using primary immune cells; the company had come highly recommended by former colleagues. We were impressed right away by the depth of knowledge of the RoukenBio team and appreciated their input on our proposed experimental plans; the RoukenBio team excelled both at communicating and executing the work. I would highly recommend working with RoukenBio."

Bijan Etemad-Gilbertson, Ph.D

Vice President - Antibody Technology - NextPoint Therapeutics

"Collaborating with RoukenBio is like a natural extension of our internal team. The level at which RoukenBio inputs and buys into the project, along with their attention to close communication and detail, is not something we experience with other CROs and are key factors that drive project success."

Emily Corse, Ph.D.

Executive Vice President, Biology & Translation

"We have worked with RoukenBio for approximately 3 years to run various immune cell based functional assays that our teams did not have the capabilities or capacity to run. We have been delighted with the quality of data, the clear collaborative communication and troubleshooting that RoukenBio has provided over the years and we look forward to continuing to work with them in our drug development processes."

Dr Angus Sinclair

Executive Vice President Research

"I am extremely pleased with the service provided by RoukenBio. Their team is incredibly knowledgeable, ensuring that all my questions are answered thoroughly. They are also highly efficient with their time, making the entire process smooth and hassle-free. Most importantly, their customer-oriented approach makes me feel valued and well taken care of. Highly recommended!"

Arnab Bera

Director, Head of Potency and Binding Assays

"We approach RoukenBio for high complexity and high priority work, leveraging the extensive domain knowledge the team has accumulated to execute a broad variety of immunology assays. Having seen the organization expand over the past 8 years, I really appreciate that the thoughtful bespoke approach and the desire to get every project right have remained the essence of every interaction."

Dr. Johanna Kaufman

Chief Scientific Officer at Deck Bio

“When we expanded from ex-vivo into in-vivo cell therapy approaches for solid tumours, external specialists such as RoukenBio allowed us to test new ideas rapidly and generated early feasibility data before making larger internal investments. In that sense, they are not just extra capacity; they are a true extension of our R&D capabilities.”

Marleen von Loenen

Head of Discovery at T-Knife Therapeutics

Maya Kotturi, Ph.D

Executive Director - Translational Research

Bijan Etemad-Gilbertson, Ph.D

Vice President - Antibody Technology - NextPoint Therapeutics

Emily Corse, Ph.D.

Executive Vice President, Biology & Translation

Dr Angus Sinclair

Executive Vice President Research

Arnab Bera

Director, Head of Potency and Binding Assays

Dr. Johanna Kaufman

Chief Scientific Officer at Deck Bio

Marleen von Loenen

Head of Discovery at T-Knife Therapeutics

Preclinical Contract Research Organisation for Immunology

Propel your drug discovery breakthroughs with RoukenBio, Discovery CRO redefined.